 |
News & Events
Macrocure Selected to Present Scientific Poster at 2013 Symposium on Advanced Wound Care (SAWC)
The poster outlines successful results of CureXcell® in treating Hard to Heal Wounds. Dr. Latricia Allen, a physician in the group of Dr. Vickie R. Driver DPM, will present a poster focusing on the positive results of a recent study conducted with the company’s flagship product, CureXcell®, at the Symposium on Advanced Wound Care - Wound Healing Society’s Annual Meeting, May 1-5 in Denver, Colorado.
For more information please Press here ______________________________________________________________ Macrocure Nominates Dr. Vickie Driver, President-elect of the American Association of Advanced Wound Care, as Lead Principal Investigator in Phase III Clinical Trial April 22nd 2013
Macrocure nominated the podiatric surgeon, Dr. Vickie R. Driver, as the Lead Principal Investigator of the company's Phase III clinical study currently being conducted in the U.S., Canada and Israel
For more information please Press here
__________________________________________________________________ MacroCure to present a lecture at Israstem 2013 Conference, to take place during April
The Lecture: “A Prospective Multi-Center 24 Week Observational Study Evaluating Wound Healing Outcomes in 131 Patients Treated with Human Activated leukocytes Suspension, an Advanced Cell Therapy", will be presesnted by Dr. Zulof-Shani on April 22nd in Kfar Hamacabia, Ramat Gan, Israel
__________________________________________________________________
MacroCure Chosen to Present Results of Multi-Center Trial of CureXCell® at Upcoming Global Diabetic Foot Conference, (DFCon) in Hollywood California USA
The Poster: “A Prospective Multi-Center 24 Week Observational Study Evaluating Wound Healing Outcomes in 131 Patients Treated with Human Activated Leukocytes Suspension, an Advanced Cell Therapy" was accepted for presentation at the upcoming DFCon Conference, set to be held between March 21 – 23 in Los Angeles.
Eurpean Patent Office to Grant Patent for Macrocure's CureXcell®
European Patent Office (EPO) intends to grant a European patent covering Marcocure’s flagship product, CureXcell®. The patent will be officially granted under an application titled “Activate Leukocyte Composition” and will provide patent coverage for CureXcell® in Europe through March 2030
"Today's Science is Tomorrow's Treatment Option: Emerging Cell Based Therapy for Difficult-to-Heal Wounds" This sponsored session by Macrocure at the Society of Advanced Wound Care (SWAC) meeting, will be held on Friday May 3rd, 2013 from 4:45 PM - 5:45 PM at theColorado Convention Center, Denver Colorado
MacroCure at the annual meeting of the Israeli Hard to Heal Wound Society, Jan 2013
Meeting will be held on Jan 3rd, 2013 at Lonardo City Tower, Ramat Gan, Israel. Please visit our booth.
|
© All rights reserved to MacroCure CureXcell™ is currently available for sale in Israel only |
 |